Invention Grant
- Patent Title: CCR2 antagonists and uses thereof
- Patent Title (中): CCR2拮抗剂及其用途
-
Application No.: US13698065Application Date: 2011-05-10
-
Publication No.: US08841313B2Publication Date: 2014-09-23
- Inventor: Heiner Ebel , Sara Frattini , Riccardo Giovannini , Christoph Hoenke , Stefan Scheuerer
- Applicant: Heiner Ebel , Sara Frattini , Riccardo Giovannini , Christoph Hoenke , Stefan Scheuerer
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- Priority: EP10162919 20100517
- International Application: PCT/EP2011/057539 WO 20110510
- International Announcement: WO2011/144501 WO 20111124
- Main IPC: A61K31/505
- IPC: A61K31/505 ; A61K31/445 ; C07D239/02 ; C07D213/02 ; C07D405/14
Abstract:
The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.
Public/Granted literature
- US20130184299A1 CCR2 ANTAGONISTS AND USES THEREOF Public/Granted day:2013-07-18
Information query
